147 related articles for article (PubMed ID: 31939313)
1. Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists.
Hurtevent A; Le Naour M; Leclerc V; Carato P; Melnyk P; Hennuyer N; Staels B; Beucher-Gaudin M; Caignard DH; Dacquet C; Lebegue N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):524-538. PubMed ID: 31939313
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.
Pirat C; Dacquet C; Leclerc V; Hennuyer N; Beucher-Gaudin M; Zanirato G; Géant A; Staels B; Ktorza A; Farce A; Caignard DH; Berthelot P; Lebegue N
Eur J Med Chem; 2017 Sep; 137():310-326. PubMed ID: 28609708
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.
Le Naour M; Leclerc V; Farce A; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Lonchampt M; Dacquet C; Ktorza A; Berthelot P; Lebegue N
ChemMedChem; 2012 Dec; 7(12):2179-93. PubMed ID: 23047286
[TBL] [Abstract][Full Text] [Related]
4. Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents.
Raval P; Jain M; Goswami A; Basu S; Gite A; Godha A; Pingali H; Raval S; Giri S; Suthar D; Shah M; Patel P
Bioorg Med Chem Lett; 2011 May; 21(10):3103-9. PubMed ID: 21450468
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
Oon Han H; Kim SH; Kim KH; Hur GC; Joo Yim H; Chung HK; Ho Woo S; Dong Koo K; Lee CS; Sung Koh J; Kim GT
Bioorg Med Chem Lett; 2007 Feb; 17(4):937-41. PubMed ID: 17157019
[TBL] [Abstract][Full Text] [Related]
6. Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.
Jia WQ; Jing Z; Liu X; Feng XY; Liu YY; Wang SQ; Xu WR; Liu JW; Cheng XC
J Biomol Struct Dyn; 2018 Oct; 36(13):3496-3512. PubMed ID: 29081262
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
Xu Y; Etgen GJ; Broderick CL; Canada E; Gonzalez I; Lamar J; Montrose-Rafizadeh C; Oldham BA; Osborne JJ; Xie C; Shi Q; Winneroski LL; York J; Yumibe N; Zink R; Mantlo N
J Med Chem; 2006 Sep; 49(19):5649-52. PubMed ID: 16970391
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of azaindole-alpha-alkyloxyphenylpropionic acid analogues as PPARalpha/gamma agonists.
Cai Z; Feng J; Guo Y; Li P; Shen Z; Chu F; Guo Z
Bioorg Med Chem; 2006 Feb; 14(3):866-74. PubMed ID: 16249089
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluations of marine oxohexadecenoic acids: PPARα/γ dual agonism and anti-diabetic target gene effects.
Sæther T; Paulsen SM; Tungen JE; Vik A; Aursnes M; Holen T; Hansen TV; Nebb HI
Eur J Med Chem; 2018 Jul; 155():736-753. PubMed ID: 29940464
[TBL] [Abstract][Full Text] [Related]
12. Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies.
Casimiro-Garcia A; Bigge CF; Davis JA; Padalino T; Pulaski J; Ohren JF; McConnell P; Kane CD; Royer LJ; Stevens KA; Auerbach BJ; Collard WT; McGregor C; Fakhoury SA; Schaum RP; Zhou H
Bioorg Med Chem; 2008 May; 16(9):4883-907. PubMed ID: 18394907
[TBL] [Abstract][Full Text] [Related]
13. NPY
Wittrisch S; Klöting N; Mörl K; Chakaroun R; Blüher M; Beck-Sickinger AG
Mol Metab; 2020 Jan; 31():163-180. PubMed ID: 31918918
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARα/γ agonists.
Zhang H; Ding CZ; Lai Z; Chen SS; Devasthale P; Herpin T; Morton G; Qu F; Ryono D; Smirk R; Wang W; Wu S; Ye XX; Li YX; Apedo A; Farrelly D; Wang T; Gu L; Morgan N; Flynn N; Chu C; Kunselman L; Lippy J; Locke K; O'Malley K; Harrity T; Cap M; Zhang L; Hosagrahara V; Kadiyala P; Xu C; Doweyko AM; Zahler R; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1196-205. PubMed ID: 25686852
[TBL] [Abstract][Full Text] [Related]
15. Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists.
Grether U; Bénardeau A; Benz J; Binggeli A; Blum D; Hilpert H; Kuhn B; Märki HP; Meyer M; Mohr P; Püntener K; Raab S; Ruf A; Schlatter D
ChemMedChem; 2009 Jun; 4(6):951-6. PubMed ID: 19326383
[TBL] [Abstract][Full Text] [Related]
16. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of [[(heterocycloamino)alkoxy] benzyl]-2,4-thiazolidinediones as PPARgamma agonists.
Jeon R; Kim YJ; Cheon Y; Ryu JH
Arch Pharm Res; 2006 May; 29(5):394-9. PubMed ID: 16756084
[TBL] [Abstract][Full Text] [Related]
18. Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
Park MH; Park JY; Lee HJ; Kim DH; Park D; Jeong HO; Park CH; Chun P; Moon HR; Chung HY
PLoS One; 2013; 8(11):e78815. PubMed ID: 24244369
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method.
Kato T; Ohara T; Suzuki N; Muto S; Tokuyama R; Mizutani M; Fukasawa H; Matsumura KI; Itai A
Bioorg Med Chem Lett; 2022 Mar; 59():128567. PubMed ID: 35063634
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
